Trifluridine/tipiracil+bevacizumab (BEV) Vs. Fluoropyrimidine-Irinotecan+bev As Second-Line Therapy for Metastatic Colorectal Cancer: a Randomised Noninferiority Trial

BRITISH JOURNAL OF CANCER(2023)

引用 5|浏览72
暂无评分
关键词
Gastrointestinal cancer,Oncology,Biomedicine,general,Cancer Research,Epidemiology,Molecular Medicine,Drug Resistance
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要